Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ABO blood groups and cancer of the pancreas.

Literature DB >> 2230362

ABO blood groups and cancer of the pancreas.

V Annese¹, M Minervini, A Gabbrielli, G Gambassi, R Manna.

Abstract

Few investigations discussing an association between ABO blood groups and pancreatic cancer exist. We have selected a series of 224 patients with histologically-confirmed pancreatic cancer, and their ABO blood groups distribution was compared with two control groups: 7086 patients with various diseases (Group 1) and 7320 voluntary blood donors (Group 2). There was an increased number of pancreatic cancer among the patients with blood group B (relative risk 1.5 vs Group 1 p = 0.021; 1.7 vs Group 2 p = 0.0025) and a decreased number in patients with blood group O, when compared with the two control groups.

Entities: Disease Gene Species

Mesh：

Substances：
ABO Blood-Group System

Year: 1990 PMID： 2230362 DOI： 10.1007/bf02933042

Source DB: PubMed Journal: Int J Pancreatol ISSN： 0169-4197

19 in total

1. Cancer-associated alterations of blood group antigen expression in the human pancreas.

Authors: S H Itzkowitz; M Yuan; L D Ferrell; R M Ratcliffe; Y S Chung; K Satake; K Umeyama; R T Jones; Y S Kim
Journal: J Natl Cancer Inst Date: 1987-09 Impact factor: 13.506

2. Controversy in human genetics. ABO blood groups and disease.

Authors: F Vogel
Journal: Am J Hum Genet Date: 1970-07 Impact factor: 11.025

3. Pancreatic cancer: the greatest oncological challenge.

Authors: R C Williamson
Journal: Br Med J (Clin Res Ed) Date: 1988-02-13

4. Lewis blood-type may affect the incidence of gastrointestinal cancer.

Authors: H Koprowski; M Brockhaus; M Blaszczyk; J Magnani; Z Steplewski; V Ginsburg
Journal: Lancet Date: 1982-06-12 Impact factor: 79.321

5. The epidemiologic approach to studies of association between HLA and disease. II. Estimation of absolute risks, etiologic and preventive fraction.

Authors: A Green
Journal: Tissue Antigens Date: 1982-04

6. Surface membrane glycoproteins of cultured human pancreatic cancer cells.

Authors: Y S Kim; D Tsao; J Hicks; L J McIntyre
Journal: Cancer Date: 1981-03-15 Impact factor: 6.860

7. Controversy in human genetics. Blood groups and disease.

Authors: A S Wiener
Journal: Am J Hum Genet Date: 1970-07 Impact factor: 11.025

8. Tissue isoantigens A, B, and H in carcinoma of the pancreas.

Authors: I Davidsohn; L Y Ni; R Stejskal
Journal: Cancer Res Date: 1971-09 Impact factor: 12.701

9. Correlative studies on antigenicity of pancreatic cancer and blood group types.

Authors: E Uchida; M A Tempero; D A Burnett; Z Steplewski; P M Pour
Journal: Cancer Detect Prev Suppl Date: 1987

10. Cancer of the pancreas in two brothers and one sister.

Authors: P Ghadirian; A Simard; J Baillargeon
Journal: Int J Pancreatol Date: 1987 Oct-Dec

19 in total

1. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.

Authors: Brian M Wolpin; Peter Kraft; Mousheng Xu; Emily Steplowski; Martin L Olsson; Alan A Arslan; H Bas Bueno-de-Mesquita; Myron Gross; Kathy Helzlsouer; Eric J Jacobs; Andrea LaCroix; Gloria Petersen; Rachael Z Stolzenberg-Solomon; Wei Zheng; Demetrius Albanes; Naomi E Allen; Laufey Amundadottir; Melissa A Austin; Marie-Christine Boutron-Ruault; Julie E Buring; Federico Canzian; Stephen J Chanock; J Michael Gaziano; Edward L Giovannucci; Göran Hallmans; Susan E Hankinson; Robert N Hoover; David J Hunter; Amy Hutchinson; Kevin B Jacobs; Charles Kooperberg; Julie B Mendelsohn; Dominique S Michaud; Kim Overvad; Alpa V Patel; Maria-José Sanchéz; Leah Sansbury; Xiao-Ou Shu; Nadia Slimani; Geoffrey S Tobias; Dimitrios Trichopoulos; Paolo Vineis; Kala Visvanathan; Jarmo Virtamo; Jean Wactawski-Wende; Joanne Watters; Kai Yu; Anne Zeleniuch-Jacquotte; Patricia Hartge; Charles S Fuchs
Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-10-22 Impact factor: 4.254

ABO blood groups and cancer of the pancreas.

1. Cancer-associated alterations of blood group antigen expression in the human pancreas.

2. Controversy in human genetics. ABO blood groups and disease.

3. Pancreatic cancer: the greatest oncological challenge.

4. Lewis blood-type may affect the incidence of gastrointestinal cancer.

5. The epidemiologic approach to studies of association between HLA and disease. II. Estimation of absolute risks, etiologic and preventive fraction.

6. Surface membrane glycoproteins of cultured human pancreatic cancer cells.

7. Controversy in human genetics. Blood groups and disease.

8. Tissue isoantigens A, B, and H in carcinoma of the pancreas.

9. Correlative studies on antigenicity of pancreatic cancer and blood group types.

10. Cancer of the pancreas in two brothers and one sister.

1. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.

Review 2. Beyond immunohaematology: the role of the ABO blood group in human diseases.

3. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis.

4. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China.

5. ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women.

6. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.

7. ABO blood group and chronic pancreatitis risk in the NAPS2 cohort.

8. Significant association between ABO blood group and pancreatic cancer.

9. ABO blood group and the risk of pancreatic cancer.

Review 10. Hemostasis, cancer, and ABO blood group: the most recent evidence of association.